{"entity":{"id":"1c9d1975-d54f-598c-a128-469ad3916a3f","name":"SHIRE PHARMACEUTICALS GROUP","type":"Organization","kind":"company","jurisdiction":"GB","identifier":"icij:icijol-56031515","risk":"LOW","flags":[]},"identity":{"linked_records":[{"id":"b6c31931-5661-5f94-99d1-762cd9ecd8cc","name":"SHIRE PHARMACEUTICALS GROUP","jurisdiction":"GB","identifier":"lei:549300QSP5QPUO6EQ075","registry":"gleif"}],"also_known_in":["gleif"]},"ownership":{"direct_owners":[],"holdings":[{"role":"shareholder of","share":null,"asset":{"id":"c4612ccb-69a8-5f77-a786-3b5fdcbab07a","name":"SHIRE PHARMACEUTICAL INVESTMENT LIMITED","type":"Company","kind":"company"}}],"ubo_chain":[]},"risk":{"level":"LOW","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"sources":[{"registry":"icij_offshoreleaks","source_url":"https://offshoreleaks.icij.org/nodes/56031515"}],"source":"corpus"}